Literature DB >> 7373412

The effects of deferoxamine mesylate on gallium-67 distribution in normal and abscess-bearing animals: concise communication.

Z H Oster, P Som, D F Sacker, H L Atkins.   

Abstract

Deferoxamine mesylate (DFO), given to rabbits 20 min after gallium-67 citrate, induces prompt and rapid urinary excretion of Ga-67 activity with concommitant decrease in blood and muscle activity. When DFO is given after 2 hr or later, the effect is smaller (15% decrease in blood activity compared with 50%). In abscess-bearing rats the same effect was observed: DFO accelerated the Ga-67 blood clearance by increasing urinary excretion. Tissue-distribution studies and direct counting of abscesses showed that DFO lowers Ga-67 activity in all organs as well as in the abscess if given 2 or 4 hr after Ga-67 citrate, but the abscess-to-blood ratio increases. At 24 hr after Ga-67 citrate, DFO administration causes an improvement in the ratios of abscess-to-blood and abscess-to-normal tissue. Thus, DFO could be used to decrease the radiation burden from Ga-67 citrate after imaging has been performed, and also to increase the target-to-nontarget ratio.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373412

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  The role of ferritin in the intracellular distribution of gallium 67.

Authors:  K Nakamura; H Kawaguchi; K Shimizu; H Orii
Journal:  Eur J Nucl Med       Date:  1984

2.  Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.

Authors:  K Koizumi; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1982

3.  Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine.

Authors:  S Nagamachi; H Hoshi; S Jinnouchi; S Ono; K Watanabe
Journal:  Ann Nucl Med       Date:  1988-05       Impact factor: 2.668

Review 4.  Translating a radiolabeled imaging agent to the clinic.

Authors:  Gary L Griffiths; Crystal Vasquez; Freddy Escorcia; Jeff Clanton; Liza Lindenberg; Esther Mena; Peter L Choyke
Journal:  Adv Drug Deliv Rev       Date:  2021-12-20       Impact factor: 15.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.